Advertisement

Personalized management of elderly patients with rectal cancer: Expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Surgeons Commission on Cancer

Published:August 14, 2018DOI:https://doi.org/10.1016/j.ejso.2018.08.003

      Abstract

      With an expanding elderly population and median rectal cancer detection age of 70 years, the prevalence of rectal cancer in elderly patients is increasing. Management is based on evidence from younger patients, resulting in substandard treatments and poor outcomes. Modern management of rectal cancer in the elderly demands patient-centered treatment, assessing frailty rather than chronological age. The heterogeneity of this group, combined with the limited available data, impedes drafting evidence-based guidelines. Therefore, a multidisciplinary task force convened experts from the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology and the American College Surgeons Commission on Cancer, with the goal of identifying the best practice to promote personalized rectal cancer care in older patients.
      A crucial element for personalized care was recognized as the routine screening for frailty and geriatrician involvement and personalized care for frail patients. Careful patient selection and improved surgical and perioperative techniques are responsible for a substantial improvement in rectal cancer outcomes. Therefore, properly selected patients should be considered for surgical resection. Local excision can be utilized when balancing oncologic outcomes, frailty and life expectancy. Watch and wait protocols, in expert hands, are valuable for selected patients and adjuncts can be added to improve complete response rates. Functional recovery and patient-reported outcomes are as important as oncologic-specific outcomes in this age group. The above recommendations and others were made based on the best-available evidence to guide the personalized treatment of elderly patients with rectal cancer.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Lawler M.
        • Selby P.
        • Aapro M.S.
        • Duffy S.
        Ageism in cancer care: time to change the mindset.
        BMJ. 2014; 348 (g1614)
        • De Angelis R.
        • Sant M.
        • Coleman M.P.
        • Francisci S.
        • Baili P.
        • Pierannunzio D.
        • et al.
        EUROCARE-5 Working Group. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 – a population-based study.
        Lancet Oncol. 2014; 15: 23-34
      1. National cancer intelligence Network. Major resections by cancer site, in England; 2006 to 2010. National cancer intelligence Network short report. http://www.ncin.org.uk/about_ncin/major_resections [Accessed March 13, 2018].

        • Lawler M.
        • Alsina D.
        • Adams R.A.
        • Anderson A.S.
        • Brown G.
        • Fearnhead N.S.
        • et al.
        Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.
        Gut. 2018 Jan; 67: 179-193
      2. http://seer.cancer.gov/csr/1975_2014/ [Accessed March 13, 2018].

      3. www.cijfersoverkanker.nl The Netherlands cancer registry [Accessed March 13, 2018].

        • Speelman A.D.
        • van Gestel Y.R.
        • Rutten H.J.
        • de Hingh I.H.
        • Lemmens V.E.
        Changes in gastrointestinal cancer resection rates.
        Br J Surg. 2015 Aug; 102: 1114-1122
        • van Gestel Y.R.
        • Lemmens V.E.
        • de Hingh I.H.
        • Steevens J.
        • Rutten H.J.
        • Nieuwenhuijzen G.A.
        • et al.
        Influence of comorbidity and age on 1-, 2-, and 3-month postoperative mortality rates in gastrointestinal cancer patients.
        Ann Surg Oncol. 2013 Feb; 20: 371-380
        • Papamichael D.
        • Audisio R.A.
        • Glimelius B.
        • de Gramont A.
        • Glynne-Jones R.
        • Haller D.
        • et al.
        Treatment of colorectal cancer in older patients: international Society of Geriatric Oncology (SIOG) consensus recommendations 2013.
        Ann Oncol. 2015 Mar; 26: 463-476
        • Balducci L.
        Aging, frailty, and chemotherapy.
        Cancer Contr. 2007; 14: 7-12
        • Hamaker M.E.
        • Wildes T.M.
        • Rostoft S.
        Time to stop saying geriatric assessment is too time consuming.
        J Clin Oncol. 2017; 35: 2871-2874
        • Fagard K.
        • Casaer J.
        • Wolthuis A.
        • Flamaing J.
        • Milisen K.
        • Lobelle J.P.
        • et al.
        Value of geriatric screening and assessment in predicting postoperative complications in patients older than 70 years undergoing surgery for colorectal cancer.
        J Geriatr Oncol. 2017; 8: 320-327
        • Fagard K.
        • Leonard S.
        • Deschodt M.
        • Devriendt E.
        • Wolthuis A.
        • Prenen H.
        • et al.
        The impact of frailty on postoperative outcomes in individuals aged 65 and over undergoing elective surgery for colorectal cancer: a systematic review.
        J Geriatr Oncol. 2016 Nov; 7: 479-491
        • Jones T.S.
        • Dunn C.L.
        • Wu D.S.
        • Cleveland Jr., J.C.
        • Kile D.
        • Robinson T.N.
        Relationship between asking an older adult about falls and surgical outcomes.
        JAMA Surg. 2013; 148: 1132-1138
        • Baitar A.
        • Van Fraeyenhove F.
        • Vandebroek A.
        • Droogh E.
        • Galdermans D.
        • Mebis J.
        • et al.
        Evaluation of the Groningen Frailty Indicator and the G8 questionnaire as screening tools for frailty in older patients with cancer.
        J Geriatr Oncol. 2013; 4: 32-38
        • Robinson T.N.
        • Wu D.S.
        • Pointer L.F.
        • Dunn C.L.
        • Moss M.
        Preoperative cognitive dysfunction is related to adverse postoperative outcomes in the elderly.
        J Am Coll Surg. 2012; 215: 12-17
        • Huisman M.G.
        • van Leeuwen B.L.
        • Ugolini G.
        • Montroni I.
        • Spiliotis J.
        • Stabilini C.
        • et al.
        “Timed up & Go”: a screening tool for predicting 30-day morbidity in onco-geriatric surgical patients? A multicenter cohort study.
        PLoS One. 2014; 9: e86863
        • Extermann M.
        • Aapro M.
        • Bernabei R.
        • Cohen H.J.
        • Droz J.P.
        • Lichtman S.
        • et al.
        Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).
        Crit Rev Oncol Hematol. 2005 Sep; 55: 241-252
        • Lawler M.
        • Le Chevalier T.
        • Banks I.
        • Conte P.
        • De Lorenzo F.
        • Meunier F.
        • et al.
        European cancer concord (ECC). A Bill of rights for patients with cancer in Europe.
        Lancet Oncol. 2014; 15: 258-260
        • Lawler M.
        • Le Chevalier T.
        • Murphy Jr., M.J.
        • Banks I.
        • Conte P.
        • De Lorenzo F.
        • et al.
        A catalyst for change: the European cancer Patient's Bill of Rights.
        Oncologist. 2014; 19: 217-224
        • Junejo M.A.
        • Mason J.M.
        • Sheen A.J.
        Cardiopulmonary exercise testing for preoperative risk assessment before hepatic resection.
        Br J Surg. 2012; 99: 1097-1104
        • West M.A.
        • Lythgoe D.
        • Barben C.P.
        • Noble L.
        • Kemp G.J.
        • Jack S.
        • et al.
        Cardiopulmonary exercise variables are associated with postoperative morbidity after major colonic surgery: a prospective blinded observational study.
        Br J Anaesth. 2014; 112: 665-671
        • Moran J.
        • Wilson F.
        • Guinan E.
        • McCormick P.
        • Hussey J.
        • Moriarty J.
        Role of cardiopulmonary exercise testing as a risk-assessment method in patients undergoing intra-abdominal surgery: a systematic review.
        Br J Anaesth. 2016; 116: 177-191
        • Pecorelli N.
        • Fiore Jr., J.F.
        • Gillis C.
        • Awasthi R.
        • Mappin-Kasirer B.
        • Niculiseanu P.
        • et al.
        The six-minute walk test as a measure of postoperative recovery after colorectal resection: further examination of its measurement properties.
        Surg Endosc. 2016; 30: 2199-2206
        • Keeratichananont W.
        • Thanadetsuntorn C.
        • Keeratichananont S.
        Value of preoperative 6-minute walk test for predicting postoperative pulmonary complications.
        Ther Adv Respir Dis. 2016; 10: 18-25
        • Moran J.
        • Wilson F.
        • Guinan E.
        • McCormick P.
        • Hussey J.
        • Moriarty J.
        The preoperative use of field tests of exercise tolerance to predict postoperative outcome in intra-abdominal surgery: a systematic review.
        J Clin Anesth. 2016; 35: 446-455
        • Mayo N.E.
        • Feldman L.
        • Scott S.
        • Zavorsky G.
        • Kim D.J.
        • Charlebois P.
        • et al.
        Impact of preoperative change in physical function on postoperative recovery: argument supporting prehabilitation for colorectal surgery.
        Surgery. 2011; 150: 505-514
        • Brunet J.
        • Burke S.
        • Grocott M.P.
        • West M.A.
        • Jack S.
        The effects of exercise on pain, fatigue, insomnia, and health perceptions in patients with operable advanced stage rectal cancer prior to surgery: a pilot trial.
        BMC Cancer. 2017; 17: 153
      4. http://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-exercise-to-help-recovery-after-bowel-cancer-surgery-prepare-abc [Assessed March 3, 2018].

        • Carli F.
        • Charlebois P.
        • Stein B.
        • Feldman L.
        • Zavorsky G.
        • Kim D.J.
        • et al.
        Randomized clinical trial of prehabilitation in colorectal surgery.
        Br J Surg. 2010; 97: 1187-1197
        • Minnella E.M.
        • Awasthi R.
        • Gillis C.
        • Fiore J.F.
        • Liberman A.S.
        • Charlebois P.
        • et al.
        Patients with poor baseline walking capacity are most likely to improve their functional status with multimodal prehabilitation.
        Surgery. 2016; 160: 1070-1079
        • West M.A.
        • Loughney L.
        • Lythgoe D.
        • Barben C.P.
        • Sripadam R.
        • Kemp G.J.
        • et al.
        Effect of prehabilitation on objectively measured physical fitness after neoadjuvant treatment in preoperative rectal cancer patients: a blinded interventional pilot study.
        Br J Anaesth. 2015; 114: 244-251
        • Gillis C.
        • Loiselle S.E.
        • Fiore Jr., J.F.
        • Awasthi R.
        • Wykes L.
        • Liberman A.S.
        • et al.
        Prehabilitation with whey protein supplementation on perioperative functional exercise capacity in patients undergoing colorectal resection for cancer: a pilot double-blinded randomized placebo-controlled trial.
        J Acad Nutr Diet. 2016; 116: 802-812
        • Huisman M.G.
        • Veronese G.
        • Audisio R.A.
        • Ugolini G.
        • Montroni I.
        • de Bock G.H.
        • et al.
        Poor nutritional status is associated with other geriatric domain impairments and adverse postoperative outcomes in onco-geriatric surgical patients - a multicentre cohort study.
        Eur J Surg Oncol. 2016; 42: 1009-1017
        • Sandrucci S.
        • Beets G.
        • Braga M.
        • Dejong K.
        • Demartines N.
        Perioperative nutrition and enhanced recovery after surgery in gastrointestinal cancer patients. A position paper by the ESSO Task Force in collaboration with the ERAS Society (ERAS Coalition). Article in Press.
        Eur J Surg Oncol. 2018; S0748–7983: 30041-30046
        • Santa Mina D.
        • Clarke H.
        • Ritvo P.
        • Leung Y.W.
        • Matthew A.G.
        • Katz J.
        • et al.
        Effect of total-body prehabilitation on postoperative outcomes: a systematic review and meta-analysis.
        Physiotherapy. 2014; 100: 196-207
        • Li C.
        • Carli F.
        • Lee L.
        • Charlebois P.
        • Stein B.
        • Liberman A.S.
        • et al.
        Impact of a trimodal prehabilitation program on functional recovery after colorectal cancer surgery: a pilot study.
        Surg Endosc. 2013; 27: 1072-1082
        • Rutten H.J.
        • den Dulk M.
        • Lemmens V.E.
        • van de Velde C.J.
        • Marijnen C.A.
        Controversies of total mesorectal excision for rectal cancer in elderly patients.
        Lancet Oncol. 2008; 9: 494-501
        • Walter L.C.
        • Covinsky K.E.
        Cancer screening in elderly patients: a framework for individualized decision making.
        JAMA. 2001; 285: 2750-2756
        • Chen K.
        • Cao G.
        • Chen B.
        • Wang M.
        • Xu X.
        • Cai W.
        • et al.
        Laparoscopic versus open surgery for rectal cancer: a meta-analysis of classic randomized controlled trials and high-quality Nonrandomized Studies in the last 5 years.
        Int J Surg. 2017; 39: 1-10
        • Bonjer H.J.
        • Deijen C.L.
        • Abis G.A.
        • Cuesta M.A.
        • van der Pas M.H.
        • de Lange-de Klerk E.S.
        • et al.
        COLOR II Study Group. A randomized trial of laparoscopic versus open surgery for rectal cancer.
        N Engl J Med. 2015; 372: 1324-1332
        • Guillou P.J.
        • Quirke P.
        • Thorpe H.
        • Walker J.
        • Jayne D.G.
        • Smith A.M.
        • et al.
        Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicenter, randomised controlled trial.
        Lancet. 2005; 365: 1718-1726
        • Nelson H.
        • Sargent D.J.
        • Wieand H.S.
        • Fleshman J.
        • Anvari M.
        • Stryker S.J.
        • et al.
        Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer.
        N Engl J Med. 2004; 350: 2050-2059
        • Jeong S.Y.
        • Park J.W.
        • Nam B.H.
        • Kim S.
        • Kang S.B.
        • Lim S.B.
        • et al.
        Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial.
        Lancet Oncol. 2014; 15: 767-774
        • Vennix S.
        • Pelzers L.
        • Bouvy N.
        • Beets G.L.
        • Pierie J.P.
        • Wiggers T.
        • et al.
        Laparoscopic versus open total mesorectal excision for rectal cancer.
        Cochrane Database Syst Rev. 2014; 4 (CD005200)
        • Zheng J.
        • Feng X.
        • Yang Z.
        • Hu W.
        • Luo Y.
        • Li Y.
        The comprehensive therapeutic effects of rectal surgery are better in laparoscopy: a systematic review and meta-analysis.
        Oncotarget. 2017; 8: 12717-12729
        • Fleshman J.
        • Branda M.
        • Sargent D.J.
        • Boller A.M.
        • George V.
        • Abbas M.
        • et al.
        Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial.
        JAMA. 2015; 314: 1346-1355
        • Stevenson A.R.
        • Solomon M.J.
        • Lumley J.W.
        • Hewett P.
        • Clouston A.D.
        • Gebski V.J.
        • et al.
        Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial.
        JAMA. 2015; 314: 1356-1363
        • Koedam T.W.A.
        • Bonjer H.J.
        • Lacy A.M.
        Pathologic outcomes of laparoscopic vs open mesorectal excision for rectal cancer.
        JAMA Surg. 2017; 152: 986
        • Fleshman J.
        • Branda M.E.
        • Sargent D.J.
        • Boller A.M.
        • George V.V.
        • Abba M.A.
        • et al.
        Disease-free Survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized controlled trial.
        Ann Surg. 2018, Aug 3; ([Epub ahead of print])https://doi.org/10.1097/SLA.0000000000003002
        • Li Y.
        • Wang S.
        • Gao S.
        • Yang C.
        • Yang W.
        • Guo S.
        Laparoscopic colorectal resection versus open colorectal resection in octogenarians: a systematic review and meta-analysis of safety and efficacy.
        Tech Coloproctol. 2016; 20: 153-162
        • Lee L.
        • Dietz D.W.
        • Fleming F.J.
        • Remzi F.H.
        • Wexner S.D.
        • Winchester D.
        • et al.
        Accreditation readiness in US multidisciplinary rectal cancer care: a survey of OSTRICH member institutions.
        JAMA Surg. 2017 Dec 13; https://doi.org/10.1001/jamasurg.2017.4871
        • Monson J.R.
        • Probst C.P.
        • Wexner S.D.
        • Remzi F.H.
        • Fleshman J.W.
        • Garcia-Aguilar J.
        • et al.
        Consortium for Optimizing the Treatment of Rectal Cancer (OSTRiCh). Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography.
        Ann Surg. 2014; 260: 625-631
        • Archampong D.
        • Borowski D.
        • Wille-Jørgensen P.
        • Iversen L.H.
        Workload and surgeon's specialty for outcome after colorectal cancer surgery.
        Cochrane Database Syst Rev. 2012; 3: CD005391
        • Beets G.
        • Sebag-Montefiore D.
        • Andritsch E.
        • Arnold D.
        • Beishon M.
        • Crul M.
        • et al.
        ECCO essential requirements for quality cancer care: colorectal cancer. A critical review.
        Crit Rev Oncol Hematol. 2017; 110: 81-93
        • Jayne D.
        • Pigazzi A.
        • Marshall H.
        • Croft J.
        • Corrigan N.
        • Copeland J.
        • et al.
        Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial.
        JAMA. 2017; 318: 1569-1580
        • Kim M.J.
        • Park S.C.
        • Park J.W.
        • Chang H.J.
        • Kim D.Y.
        • Nam B.H.
        • et al.
        Robot-assisted versus laparoscopic surgery for rectal cancer: a phase II open label prospective randomized controlled trial.
        Ann Surg. 2018; 267: 243-251
        • Adamina M.
        • Buchs N.C.
        • Penna M.
        • Hompes R.
        St. Gallen Colorectal Consensus Expert Group. St. Gallen consensus on safe implementation of transanal total mesorectal excision.
        Surg Endosc. 2017 Dec 12; ([Epub ahead of print])https://doi.org/10.1007/s00464-017-5990-2
        • Penna M.
        • Cunningham C.
        • Hompes R.
        Transanal total mesorectal excision: why, when, and how.
        Clin Colon Rectal Surg. 2017; 30: 339-345
        • Simillis C.
        • Hompes R.
        • Penna M.
        • Rasheed S.
        • Tekkis P.P.
        A systematic review of transanal total mesorectal excision: is this the future of rectal cancer surgery?.
        Colorectal Dis. 2016; 18: 19-36
      5. https://tatme.medicaldata.eu/ [Accessed January 22, 2018].

      6. http://www.lorec.nhs.uk [Accessed January 22, 2018].

        • Bach P.
        • Hill J.
        • Monson J.R.
        • Simson J.N.
        • Lane L.
        • Merrie A.
        • et al.
        Association of Coloproctology of Great Britain and Ireland Transanal Endoscopic Microsurgery (TEM) Collaboration. A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer.
        Br J Surg. 2009; 96: 280-290
        • Kawachi H.
        • Eishi Y.
        • Ueno H.
        • Nemoto T.
        • Fujimori T.
        • Iwashita A.
        • et al.
        A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study.
        Mod Pathol. 2015; 28: 872-879
        • Martin-Perez B.
        • Andrade-Ribeiro G.D.
        • Hunter L.
        • Atallah S.
        A systematic review of transanal minimally invasive surgery (TAMIS) from 2010 to 2013.
        Tech Coloproctol. 2014; 18: 775-788
        • Hallam S.
        • Messenger D.E.
        • Thomas M.G.
        A systematic review of local excision after neoadjuvant therapy for rectal cancer: are ypT0 tumors the limit?.
        Dis Colon Rectum. 2016; 59: 984-997
        • Smith F.M.
        • Ahad A.
        • Perez R.O.
        • Marks J.
        • Bujko K.
        • Heald R.J.
        Local excision techniques for rectal cancer after neoadjuvant chemoradiotherapy: what are we doing?.
        Dis Colon Rectum. 2017; 60: 228-239
        • Perez R.O.
        • Habr-Gama A.
        • São Julião G.P.
        • Proscurshim I.
        • Scanavini Neto A.
        • Gama-Rodrigues J.
        Transanal endoscopic microsurgery for residual rectal cancer after neoadjuvant chemoradiation therapy is associated with significant immediate pain and hospital readmission rates.
        Dis Colon Rectum. 2011; 54: 545-551
        • Borstlap W.A.
        • Coeymans T.J.
        • Tanis P.J.
        • Marijnen C.A.
        • Cunningham C.
        • Bemelman W.A.
        • et al.
        Meta-analysis of oncological outcomes after local excision of pT1-2 rectal cancer requiring adjuvant (chemo)radiotherapy or completion surgery.
        Br J Surg. 2016; 103: 1105-1116
        • Kapiteijn E.
        • Marijnen C.A.
        • Nagtegaal I.D.
        • Putter H.
        • Steup W.H.
        • Wiggers T.
        • et al.
        Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.
        N Engl J Med. 2001; 345: 638-646
        • Bosset J.F.
        • Calais G.
        • Mineur L.
        • Maingon P.
        • Radosevic-Jelic L.
        • Daban A.
        • et al.
        Enhanced tumoricidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results – EORTC 22921.
        J Clin Oncol. 2005; 23: 5620-5627
        • Gérard J.P.
        • Conroy T.
        • Bonnetain F.
        • Bouché O.
        • Chapet O.
        • Closon-Dejardin M.T.
        • et al.
        Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.
        J Clin Oncol. 2006; 24: 4620-4625
        • Sauer R.
        • Becker H.
        • Hohenberger W.
        • Rödel C.
        • Wittekind C.
        • Fietkau R.
        • et al.
        German Rectal Cancer Study Group. Preoperative vs postoperative chemoradiotherapy for rectal cancer.
        N Engl J Med. 2004; 351: 1731-1740
        • Sebag-Montefiore D.
        • Stephens R.J.
        • Steele R.
        • Monson J.
        • Grieve R.
        • Khanna S.
        • et al.
        Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.
        Lancet. 2009; 373: 811-820
        • Aschele C.
        • Cionini L.
        • Lonardi S.
        • Pinto C.
        • Cordio S.
        • Rosati G.
        • et al.
        Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.
        J Clin Oncol. 2011; 29: 2773-2780
        • Gerard J.P.
        • Glynne-Jones R.
        • Blackstock W.
        • Aschele C.
        • van de Velde C.
        Radiochemotherapy in rectal cancer: the role of oxaliplatin.
        Colorectal Dis. 2003; 5: 29-35
        • Rödel C.
        • Grabenbauer G.G.
        • Papadopoulos T.
        • Hohenberger W.
        • Schmoll H.J.
        • Sauer R.
        Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.
        J Clin Oncol. 2003; 21: 3098-3104
        • Deng Y.
        • Chi P.
        • Lan P.
        • Wang L.
        • Chen W.
        • Cui L.
        • et al.
        Modified FOLFOX6 with or without radiation versus fluorouracil and leucovorin with radiation in neoadjuvant treatment of locally advanced rectal cancer: initial results of the Chinese FOWARC multicenter, open-label, randomized three-arm phase III trial.
        J Clin Oncol. 2016; 34: 3300-3307
        • Schmoll H.-J.
        • Haustermans K.
        • Price T.J.
        • Nordlinger B.
        • Hofheinz R.
        • Daisne J.-F.
        • et al.
        Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: first results of the PETACC-6 randomized trial.
        Proc Am Soc Clin Oncol. 2014; 32 (abstract 3501)
        • Nilsson P.J.
        • van Etten B.
        • Hospers G.A.
        • Påhlman L.
        • van de Velde C.J.
        • Beets-Tan R.G.
        • et al.
        Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer–the RAPIDO trial.
        BMC Cancer. 2013; 13: 279
        • Ngan S.Y.
        • Burmeister B.
        • Fisher R.J.
        • Solomon M.
        • Goldstein D.
        • Joseph D.
        • et al.
        Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: trans-Tasman Radiation Oncology Group trial 01.04.
        J Clin Oncol. 2012; 30: 3827-3833
        • François E.
        • Azria D.
        • Gourgou-Bourgade S.
        • Jarlier M.
        • Martel-Laffay I.
        • Hennequin C.
        • et al.
        Results in the elderly with locally advanced rectal cancer from the ACCOR12/PRODIGE 2 phase III trial: tolerance and efficacy.
        Radiother Oncol. 2014; 110: 144-149
      7. https://clinicaltrials.gov/ct2/show/NCT02551237 [Accessed December 18, 2017].

        • Monson J.R.
        • Weiser M.R.
        • Buie W.D.
        • Chang G.J.
        • Rafferty J.F.
        • Buie W.D.
        • et al.
        Standards practice task force of the american society of colon and rectal surgeons. Practice parameters for the management of rectal cancer (revised).
        Dis Colon Rectum. 2013; 56: 535-550
        • Lefevre J.H.
        • Parc Y.
        Tiret E French research group of rectal cancer surgery (GRECCAR). Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer.
        Ann Surg. 2015; 262: e116
        • Pach R.
        • Kulig J.
        • Richter P.
        • Gach T.
        • Szura M.
        • Kowalska T.
        Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer – treatment results at 5-year follow-up.
        Langenbeck's Arch Surg. 2012; 397 (801–710)
        • Frykholm G.J.
        • Påhlman L.
        • Glimelius B.
        Combined chemo- and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum.
        Int J Radiat Oncol Biol Phys. 2001; 50: 427-434
        • Appelt A.L.
        • Pløen J.
        • Vogelius I.R.
        • Bentzen S.M.
        • Jakobsen A.
        Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy.
        Int J Radiat Oncol Biol Phys. 2013; 85: 74-80
        • Habr-Gama A.
        • Sabbaga J.
        • Gama-Rodrigues J.
        • São Julião G.P.
        • Proscurshim I.
        • Bailão Aguilar P.
        • et al.
        Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?.
        Dis Colon Rectum. 2013; 56: 1109-1117
        • Gerard J.P.
        • Chapet O.
        • Ortholan C.
        • Benezery K.
        • Barbet N.
        • Romestaing P.
        French experience with contact X-ray endocavitary radiation for early rectal cancer.
        Clin Oncol (R Coll Radiol). 2007; 19: 661-673
        • Papillon J.
        Intracavitary irradiation of early rectal cancer for cure. A series of 186 cases.
        Cancer. 1975; 36: 696e701
        • Gerard J.P.
        • Chapet O.
        • Romestaing P.
        • Favrel V.
        • Barbet N.
        • Mornex F.
        Local excision and adjuvant radiotherapy for rectal adenocarcinoma T1-2 N0.
        Gastroenterol Clin Biol. 2000; 24: 430e5
        • Frin A.C.
        • Evesque L.
        • Gal J.
        • Benezery K.
        • François E.
        • Gugenheim J.
        • et al.
        Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients.
        Eur J Cancer. 2017; 72: 124-136
        • Papillon J.
        Present status of radiation therapy in the conservative management of rectal cancer.
        Radiother Oncol. 1990; 17 (275e83)
        • Gerard J.P.
        • Chapet O.
        • Ramaioli A.
        • Romestaing P.
        Long-term control of T2eT3 rectal adenocarcinoma with radiotherapy alone.
        Int J Radiat Oncol Biol Phys. 2002; 54 (142e9)
      8. https://clinicaltrials.gov/ct2/show/NCT02505750 [Accessed January 11, 2018].

      9. nice.org.uk/guidance/ipg532 Low energy contact X ray brachytherapy (the Papillon technique) for early stage rectal cancer [Accessed January 11, 2018].

        • Corner C.
        • Bryant L.
        • Chapman C.
        • Glynne-Jones R.
        • Hoskin P.J.
        High-dose-rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.
        Brachytherapy. 2010; 9: 66-70
        • Beets G.L.
        • Figueiredo N.L.
        • Habr-Gama A.
        • van de Velde C.J.
        A new paradigm for rectal cancer: organ preservation: introducing the international watch & wait database (IWWD).
        Eur J Surg Oncol. 2015 Dec; 41: 1562-1564
        • Habr-Gama A.
        • Gama-Rodrigues J.
        • Sao Juliao G.P.
        • Proscurshim I.
        • Sabbagh C.
        • Lynn P.B.
        • et al.
        Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control.
        Int J Radiat Oncol Biol Phys. 2014; 88: 822-828
        • Smith F.M.
        • Rao C.
        • Oliva Perez R.
        • Bujko K.
        • Athanasiou T.
        • Habr-Gama A.
        • et al.
        Avoiding radical surgery improves early survival in elderly patients with rectal cancer, demonstrating complete clinical response after neoadjuvant therapy: results of a decision-analytic model.
        Dis Colon Rectum. 2015; 58: 159-171
        • Dossa F.
        • Chesney T.R.
        • Acuna S.A.
        • Baxter N.N.
        A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.
        Lancet Gastroenterol Hepatol. 2017; 2: 501-513
        • Sammour T.
        • Price B.A.
        • Krause K.J.
        • Chang G.J.
        Nonoperative management or 'watch and wait' for rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy: a critical appraisal.
        Ann Surg Oncol. 2017; 24: 1904-1915
      10. van der Valk MJM, Hilling DE, Bastiaannet E. Registry of 1009 patients in the International Watch & Wait database (IWWD) for rectal cancer: Results of clinical complete responders. Submitted.

        • Gerard J.P.
        • Romestaing P.
        • Chapet O.
        Radiotherapy alone in the curative treatment of rectal carcinoma.
        Lancet Oncol. 2003; 4: 158-166
        • Sun Myint A.
        • Smith F.M.
        • Gollins S.W.
        • Wong H.
        • Rao C.
        • Whitmarsh K.
        • et al.
        Dose escalation using contact X-ray brachytherapy (Papillon) for rectal cancer: does it improve the chance of organ preservation?.
        Br J Radiol. 2017; 90: 20170175
        • Appelt A.L.
        • Pløen J.
        • Harling H.
        High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study.
        Lancet Oncol. 2015 Aug; 16: 919-927
        • Cercek A.
        • Goodman K.A.
        • Hajj C.
        • Weisberger E.
        • Segal N.H.
        • Reidy-Lagunes D.L.
        • et al.
        Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer.
        J Natl Compr Cancer Netw. 2014; 12: 513-519
        • Garcia-Aguilar J.
        • Chow O.S.
        • Smith D.D.
        Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.
        Lancet Oncol. 2015 Aug; 16: 957-966
        • Petersen S.H.
        • Harling H.
        • Kirkeby L.T.
        • Wille-Jørgensen P.
        • Mocellin S.
        Postoperative adjuvant chemotherapy in rectal cancer operated for cure.
        Cochrane Database Syst Rev. 2012; 3 (CD004078)
        • Bosset J.F.
        • Calais G.
        • Mineur L.
        • Maingon P.
        • Stojanovic-Rundic S.
        • Bensadoun R.J.
        • et al.
        Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
        Lancet Oncol. 2014; 15: 184-190
        • Sainato A.
        • Cernusco Luna Nunzia V.
        • Valentini V.
        • De Paoli A.
        • Maurizi E.R.
        • Lupattelli M.
        • et al.
        No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): long term results of a randomized trial (I-CNR-RT).
        Radiother Oncol. 2014; 113: 223-229
        • Breugom A.J.
        • van Gijn W.
        • Muller E.W.
        • Berglund A.
        • van den Broek C.B.
        • Fokstuen T.
        • et al.
        Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.
        Ann Oncol. 2015; 26: 696-701
        • Breugom A.J.
        • Swets M.
        • Bosset J.F.
        • Collette L.
        • Sainato A.
        • Cionini L.
        • et al.
        Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data.
        Lancet Oncol. 2015; 16: 200-207
        • Bujko K.
        • Glimelius B.
        • Valentini V.
        • Michalski W.
        • Spalek M.
        Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: a meta-analysis of randomized trials comparing surgery ± a fluoropyrimidine and surgery + a fluoropyrimidine ± oxaliplatin.
        Eur J Surg Oncol. 2015; 41: 713-723
      11. NCCN clinical practice guidelines in Oncology rectal cancer 3. 2017 (Available at:)
        • McCleary N.J.
        • Meyerhardt J.A.
        • Green E.
        Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database.
        J Clin Oncol. 2013; 31: 2600-2606
        • Shi Q.
        • Flowers C.R.
        • Hiddemann W.
        Thirty-Month complete response as a surrogate end point in first-line follicular lymphoma therapy: an individual patient-level analysis of multiple randomized trials.
        J Clin Oncol. 2017; 35: 552-560
        • Glynne-Jones R.
        • Wyrwicz L.
        • Tiret E.
        • Brown G.
        • Rödel C.
        • Cervantes A.
        • et al.
        Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
        Ann Oncol. 2017; 28: iv22-iv40
        • Papamichael D.
        • Audisio R.A.
        • de Gramont A.
        • Glynne-Jones R.
        • Haller D.
        Treatment of colorectal cancer in older patients: international Society of Geriatric Oncology (SIOG) consensus recommendations 2013.
        Ann Oncol. 2015; 26: 463-476
        • Manfredi S.
        • Lepage C.
        • Hatem C.
        • Coatmeur O.
        • Faivre J.
        • Bouvier A.M.
        Epidemiology and management of liver metastases from colorectal cancer.
        Ann Surg. 2006; 244: 254-259
        • Adam R.
        • de Gramont A.
        • Figueras J.
        • Kokudo N.
        • Kunstlinger F.
        • Loyer E.
        • et al.
        Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus.
        Cancer Treat Rev. 2015; 41: 729-741
      12. https://livermetsurvey-arcad.org/ Accessed December 20, 2017.

        • Adam R.
        • Frilling A.
        • Elias D.
        • Laurent C.
        • Ramos E.
        • Capussotti L.
        • et al.
        Liver resection of colorectal metastases in elderly patients.
        Br J Surg. 2010; 97: 366-376
        • Albertsmeier M.
        • Engel A.
        • Guba M.O.
        • Stintzing S.
        • Schiergens T.S.
        • Schubert-Fritschle G.
        • et al.
        Synchronous colorectal liver metastases: focus on the elderly: an Effectiveness Study from Routine Care.
        Langenbeck's Arch Surg. 2017; 402: 1223-1232
        • De'Liguori Carino N.
        • van Leeuwen B.L.
        • Ghaneh P.
        • Wu A.
        • Audisio R.A.
        • Poston G.J.
        Liver resection for colorectal liver metastases in older patients.
        Crit Rev Oncol Hematol. 2008; 67: 273-278
        • Nagano Y.
        • Nojiri K.
        • Matsuo K.
        • Tanaka K.
        • Togo S.
        • Ike H.
        • et al.
        The impact of advanced age on hepatic resection of colorectal liver metastases.
        J Am Coll Surg. 2005; 201: 511-516
        • Cook E.J.
        • Welsh F.S.K.
        • Chandrakumaran K.
        • John T.G.
        • Rees M.
        Resection of colorectal liver metastases in the elderly: does age matter?.
        Colorectal Dis. 2012; 14: 1210-1216
        • Van Cutsem E.
        • Cervantes A.
        • Adam R.
        • Sobrero A.
        • Van Krieken J.H.
        • Aderka D.
        • et al.
        ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
        Ann Oncol. 2016; 27: 1386-1422
      13. http://www.nice.org.uk/guidance/cg131/chapter/guidance National institute for health and care excellence. Colorectal cancer: the diagnosis and management of colorectal cancer. Accessed December 29, 2017.

        • Pathak S.
        • Nunes Q.M.
        • Daniels I.R.
        • Smart N.J.
        • Poston G.J.
        • Påhlman L.
        Rectal cancer with synchronous liver metastases: do we have a clear direction?.
        Eur J Surg Oncol. 2015; 41: 1570-1577
        • Wilson I.
        • Paul Barrett M.
        • Sinha A.
        • Chan S.
        Predictors of in-hospital mortality amongst octogenarians undergoing emergency general surgery: a retrospective cohort study.
        Int J Surg. 2014; 12: 1157-1161
      14. Zattoni D, Montroni I, Saur NM, Garutti A, Bacchi Reggiani ML, Galetti C, et al. Frailty screening in emergency general surgery. Effectiveness of the Flemish version of Triage Risk Screening Tool (fTRST) in predicting early and long-term morbidity and mortality among elderly patients. Submitted to the Journal of the American Geriatrics Society.

        • Cirocchi R.
        • Farinella E.
        • Trastulli S.
        • Desiderio J.
        • Listorti C.
        • Boselli C.
        • et al.
        Safety and efficacy of endoscopic colonic stenting as a bridge to surgery in the management of intestinal obstruction due to left colon and rectal cancer: a systematic review and meta-analysis.
        Surg Oncol. 2013 Mar; 22: 14-21
        • Han E.C.
        • Ryoo S.
        • Park B.K.
        • Park J.W.
        • Lee S.Y.
        • Oh H.K.
        • et al.
        Surgical outcomes and prognostic factors of emergency surgery for colonic perforation: would fecal contamination increase morbidity and mortality?.
        Int J Colorectal Dis. 2015; 30: 1495-1504
        • Patel S.S.
        • Nelson R.
        • Sanchez J.
        • Lee W.
        • Uyeno L.
        • Garcia-Aguilar J.
        • et al.
        Elderly patients with colon cancer have unique tumor characteristics and poor survival.
        Cancer. 2013; 119: 739-747
        • Baxter N.N.
        • Virnig D.J.
        • Rothenberger D.A.
        • Morris A.M.
        • Jessurun J.
        • Virnig B.A.
        Lymph node evaluation in colorectal cancer patients: a population-based study.
        J Natl Cancer Inst. 2005; 97: 219-225
        • Khan H.
        • Olszewski A.J.
        • Somasundar P.
        Lymph node involvement in colon cancer patients decreases with age; a population based analysis.
        Eur J Surg Oncol. 2014; 40: 1474-1480
        • Amri R.
        • Bordeianou L.G.
        • Berger D.L.
        The conundrum of the young colon cancer patient.
        Surgery. 2015; 158: 1696-1703
        • Jover R.
        • Nguyen T.P.
        • Pérez-Carbonell L.
        • Zapater P.
        • Payá A.
        • Alenda C.
        • et al.
        5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer.
        Gastroenterology. 2011; 140: 1174-1181
        • Tahara T.
        • Yamamoto E.
        • Suzuki H.
        • Maruyama R.
        • Chung W.
        • Garriga J.
        • et al.
        Fusobacterium in colonic flora and molecular features of colorectal carcinoma.
        Cancer Res. 2014; 74: 1311-1318
        • Amitay E.L.
        • Werner S.
        • Vital M.
        • Pieper D.H.
        • Höfler D.
        • Gierse I.J.
        • et al.
        Fusobacterium and colorectal cancer: causal factor or passenger? Results from a large colorectal cancer screening study.
        Carcinogenesis. 2017; 38: 781-788
        • Forsmo H.M.
        • Erchsen C.
        • Rasdal A.
        • Körner H.
        • Pfeffer F.
        Enhanced recovery after Colorectal Surgery (ERAS) in elderly patients is feasible and achieves similar results as in younger patients.
        Gerontol Geriatr Med. 2017; 3: 1-8
        • Bagnall N.M.
        • Malietzis G.
        • Kennedy R.H.
        • Athanasiou T.
        • Faiz O.
        • Darzi A.
        A systematic review of enhanced recovery care after colorectal surgery in elderly patients.
        Colorectal Dis. 2014; 16: 947-956
        • Launay-Savary M.V.
        • Mathonnet M.
        • Theissen A.
        • Ostermann S.
        • Raynaud-Simon A.
        • Slim K.
        Are enhanced recovery programs in colorectal surgery feasible and useful in the elderly? A systematic review of the literature.
        J Vis Surg. 2017; 154: 29-35
        • Halabi W.J.
        • Kang C.Y.
        • Nguyen V.Q.
        • Carmichael J.C.
        • Mills S.
        • Stamos M.J.
        • et al.
        Epidural analgesia in laparoscopic colorectal surgery: a nationwide analysis of use and outcomes.
        JAMA Surg. 2014; 149: 130-136
        • Chen M.
        • Song X.
        • Chen L.Z.
        • Lin Z.D.
        • Zhang X.L.
        Comparing mechanical bowel preparation with both oral and systemic antibiotics versus mechanical bowel preparation and systemic antibiotics alone for the prevention of surgical site infection after elective colorectal surgery: a meta-analysis of randomized controlled clinical trials.
        Dis Colon Rectum. 2016; 59: 70-78
        • Banks E.
        • Byles J.E.
        • Gibson R.E.
        • Rodgers B.
        • Latz I.K.
        • Robinson I.A.
        • et al.
        Is psychological distress in people living with cancer related to the fact of diagnosis, current treatment or level of disability? Findings from a large Australian study.
        Med J Aust. 2010; 193: S62-S67
        • Lindau S.T.
        • Schumm L.P.
        • Laumann E.O.
        • Levinson W.
        • O'Muircheartaigh C.A.
        • Waite L.J.
        A study of sexuality and health among older adults in the United States.
        N Engl J Med. 2007; 357: 762-774
        • Battersby N.J.
        • Juul T.
        • Christensen P.
        • Janjua A.Z.
        • Branagan G.
        • Emmertsen K.J.
        • et al.
        Predicting the risk of bowel-related quality-of-life impairment after restorative resection for rectal cancer: a multicenter cross-sectional study.
        Dis Colon Rectum. 2016; 59: 270-280
        • Hupkens B.J.P.
        • Martens M.H.
        • Stoot J.H.
        • Berbee M.
        • Melenhorst J.
        • Beets-Tan R.G.
        • et al.
        Quality of life in rectal cancer patients after chemoradiation: watch-and-wait policy versus standard resection - a matched-controlled study.
        Dis Colon Rectum. 2017; 60: 1032-1104
        • Jonker F.H.
        • Tanis P.J.
        • Coene P.P.
        • Gietelink L.
        • van der Harst E.
        Dutch Surgical Colorectal Audit Group. Comparison of a low Hartmann's procedure with low colorectal anastomosis with and without defunctioning ileostomy after radiotherapy for rectal cancer: results from a national registry.
        Colorectal Dis. 2016; 18: 785-792
        • Orsini R.G.
        • Thong M.S.
        • van de Poll-Franse L.V.
        • Slooter S.D.
        • Nieuwenhuijzen G.A.
        • Rutten H.J.
        • et al.
        Quality of life of older rectal cancer patients is not impaired by a permanent stoma.
        Eur J Surg Oncol. 2013; 39: 164-170
        • Rullier E.
        • Le Toux N.
        • Laurent C.
        • Garrelon J.L.
        • Saric Parneix M.
        Loop ileostomy versus loop colostomy for defunctioning low anastomoses during rectal cancer surgery.
        World J Surg. 2001; 25: 274-277
        • Zerillo J.A.
        • Schouwenburg M.G.
        • van Bommel A.C.M.
        • Stowell C.
        • Lippa J.
        • Bauer D.
        • et al.
        Colorectal cancer working group of the international Consortium for health outcomes measurement (ICHOM). An international collaborative standardizing a comprehensive patient-centered outcomes measurement set for colorectal cancer.
        JAMA Oncol. 2017; 3: 686-694
      15. http://www.ichom.org/ [Assessed December 7, 2017].

        • Audisio R.A.
        • Pope D.
        • Ramesh H.S.
        Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study.
        Crit Rev Oncol Hematol. 2008; 65: 156-163
        • Huisman M.G.
        • Audisio R.A.
        • Ugolini G.
        • Montroni I.
        • Vigano A.
        • Spiliotis J.
        • et al.
        Screening for predictors of adverse outcome in onco-geriatric surgical patients: a multicenter prospective cohort study.
        Eur J Surg Oncol. 2015; 41: 844-851
        • Pędziwiatr M.
        • Pisarska M.
        • Major P.
        • Grochowska A.
        • Matłok M.
        • Przęczek K.
        • et al.
        Laparoscopic colorectal cancer surgery combined with enhanced recovery after surgery protocol (ERAS) reduces the negative impact of sarcopenia on short-term outcomes.
        Eur J Surg Oncol. 2016; 42: 779-787
        • Jaklitsch M.T.
        “How am I doing? Just ask me!” the usefulness of patient self-reported quality of life in thoracic surgery.
        J Thorac Cardiovasc Surg. 2015; 149: 663-664
        • Fernando H.C.
        • Landreneau R.J.
        • Mandrekar S.J.
        • Nichols F.C.
        • DiPetrillo T.A.
        • Meyer B.F.
        • et al.
        Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trial.
        J Thorac Cardiovasc Surg. 2015; 149: 718-726
        • Himmelstein D.U.
        • Thorne D.
        • Warren E.
        • Woolhandler S.
        Medical bankruptcy in the United States, 2007: results of a national study.
        Am J Med. 2009; 122: 741-746
        • Ramsey S.
        • Blough D.
        • Kirchhoff A.
        • Kreizenbeck K.
        • Fedorenko C.
        • Snell K.
        • et al.
        Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis.
        Health Aff (Millwood). 2013; 32: 1143-1152
        • Lang K.
        • Lines L.M.
        • Lee D.W.
        • Korn J.R.
        • Earle C.C.
        • Menzin J.
        Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data.
        Clin Gastroenterol Hepatol. 2009; 7: 198-204
        • Lin H.S.
        • Watts J.N.
        • Peel N.M.
        • Hubbard R.E.
        Frailty and post-operative outcomes in older surgical patients: a systematic review.
        BMC Geriatr. 2016; 16 (31): 157
        • Jensen C.C.
        • Prasad L.M.
        • Abcarian H.
        Cost-effectiveness of laparoscopic vs open resection for colon and rectal cancer.
        Dis Colon Rectum. 2012; 55: 1017-1023
        • Ramji K.M.
        • Cleghorn M.C.
        • Josse J.M.
        • MacNeill A.
        • O'Brien C.
        • Urbach D.
        • et al.
        Comparison of clinical and economic outcomes between robotic, laparoscopic, and open rectal cancer surgery: early experience at a tertiary care center.
        Surg Endosc. 2016; 30: 1337-1343
        • Rao C.
        • Sun Myint A.
        • Athanasiou T.
        • Faiz O.
        • Martin A.P.
        • Collins B.
        • et al.
        Avoiding radical surgery in elderly patients with rectal cancer is cost-effective.
        Dis Colon Rectum. 2017; 60: 30-42
        • Näppä U.
        • Lindqvist O.
        • Rasmussen B.H.
        • Axelsson B.
        Palliative chemotherapy during the last month of life.
        Ann Oncol. 2011; 22: 2375-2380
        • Porter M.E.
        • Teisberg E.O.
        Redefining health care: creating value-based competition on results.
        Harvard Business School Press, Boston2006